March 24 (Reuters) - Biovaxys Technology Corp BIOV.CD :
* BIOVAXYS - FILING OF AN INTERNATIONAL PATENT APPLICATION FOR HAPTENIZED VIRAL ANTIGEN VACCINE PLATFORM
* BIOVAXYS - FILING OF AN INTERNATIONAL PATENT APPLICATION FOR NEW CLAIMS FOR A MULTIVALENT VERSION OF ITS SARS-COV-2 VACCINE CANDIDATE